sm-88
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 27, 2018 (NCT03512756)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04720664 | Phase 2 | Sep 22, 2021 | Georgetown University, Tyme, Inc |
| NCT04229004 | Phase 3 | Jan 10, 2020 | Pancreatic Cancer Action Network |
| NCT03512756 | Phase 2 | Mar 27, 2018 | Tyme, Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tyme, Inc | For profit | 2 | 1 | 1 | 2018 |
| Georgetown University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Pancreatic Cancer Action Network | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1